SCHEMBL30288647

SCHEMBL30288647

COC(=O)[C@H]1C[C@@H](O)C[C@H]1NC(=O)OCc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CPB1 P15086 2/20 0.69
▸ ALDH1A1 P00352 4/20 0.55
▸ TSHR P16473 3/20 0.55
▸ CYP2C9 P11712 2/20 0.55
▸ CYP2C19 P33261 2/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ CYP1A2 P05177 2/20 0.55
▸ POLB P06746 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ LMNA P02545 1/20 0.51
▸ GAA P10253 1/20 0.48
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ ACHE P22303 2/20 0.46
▸ CASP1 P29466 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ KDM1A O60341 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ EPHX1 P07099 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30288858 1.00 CPB1 (0.69) CPB1ALDH1A1TSHRCYP2C9CYP2C19
SCHEMBL29046606 1.00 CPB1 (0.69) CPB1ALDH1A1TSHRCYP2C9CYP2C19
SCHEMBL29046605 1.00 CPB1 (0.69) CPB1ALDH1A1TSHRCYP2C9CYP2C19
SCHEMBL29046618 1.00 CPB1 (0.69) CPB1ALDH1A1TSHRCYP2C9CYP2C19
SCHEMBL31045416 0.92 CPB1 (0.75) CPB1ALDH1A1TSHRCYP2C9CYP2C19
SCHEMBL17440204 0.91 CPB1 (0.74) CPB1ALDH1A1TSHRCYP2C9CYP2C19
SCHEMBL10916791 0.90 CPB1 (0.77) CPB1ALDH1A1TSHRCYP2C9CYP2C19
SCHEMBL10916786 0.90 CPB1 (0.77) CPB1ALDH1A1TSHRCYP2C9CYP2C19
SCHEMBL24515782 0.86 CPB1 (0.67) CPB1ALDH1A1TSHRCYP2C9CYP2C19
SCHEMBL30288635 0.86 CPB1 (0.67) CPB1ALDH1A1TSHRCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348363-A1 COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2023-11-02 — — US disclosed
US-11667602-B2 Compounds and their use ASTRAZENECA AB (SE) 2023-06-06 — — US disclosed
US-20230078576-A1 COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2023-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667602-B2 Compounds and their use RXFP1, RXFP3, RXFP2 CPB1 2014/4885ALDH1A1 1531/4885TSHR 436/4885
US-20230348363-A1 COMPOUNDS AND THEIR USE RXFP1, RXFP3, RXFP2 CPB1 2014/4885ALDH1A1 1531/4885TSHR 436/4885
US-20230078576-A1 COMPOUNDS AND THEIR USE RXFP1, RXFP3, RXFP2 CPB1 2014/4885ALDH1A1 1531/4885TSHR 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback